Stocks and Investing Stocks and Investing
Thu, June 21, 2018
Wed, June 20, 2018
Tue, June 19, 2018

Josh Schimmer Upgraded (BLUE) to Buy and Increased Target to $230 on, Jun 19th, 2018


Published on 2024-10-26 06:14:43 - WOPRAI, Josh Schimmer
  Print publication without navigation


Josh Schimmer of Evercore ISI Group, Upgraded "bluebird bio, Inc." (BLUE) to Buy and Increased Target from $175 to $230 on, Jun 19th, 2018.

Josh has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 2 agree with Josh's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $209 on, Wednesday, March 21st, 2018
  • Ying Huang of "B of A Securities" Maintained at Hold with Increased Target to $218 on, Thursday, February 22nd, 2018


This is the rating of the analyst that currently disagrees with Josh


  • Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $216 on, Thursday, May 3rd, 2018
Contributing Sources